Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Biomarin Pharmaceutical Inc (BMRN)
since 2005 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1048477.
Total stock buying since 2005: $2,433,737.
Total stock sales since 2005: $583,535,292.
Total stock option exercises since 2005: $188,288,866.
Table 3. Detailed insider trading at Biomarin Pharmaceutical Inc (BMRN) , Part 5
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2015-11-16 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 20,000 | 104.30 | 2,085,920 |
| 2015-11-16 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Option Ex | 20,000 | 39.06 | 781,200 |
| 2015-11-02 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 26 | 117.56 | 3,056 |
| 2015-10-15 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,000 | 108.24 | 108,241 |
| 2015-09-14 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,000 | 131.43 | 131,432 |
| 2015-09-08 | Heron Elaine J | Option Ex | 15,000 | 21.51 | 322,650 |
| 2015-08-12 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,500 | 134.72 | 202,083 |
| 2015-07-20 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 3,000 | 150.00 | 450,000 |
| 2015-07-20 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Option Ex | 3,000 | 63.10 | 189,300 |
| 2015-07-07 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,500 | 139.07 | 208,599 |
| 2015-06-05 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 1,649 | 122.30 | 201,669 |
| 2015-06-05 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 1,864 | 122.32 | 228,000 |
| 2015-06-04 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 1,362 | 122.35 | 166,646 |
| 2015-06-01 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 377 | 123.76 | 46,656 |
| 2015-06-01 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 3,945 | 124.16 | 489,811 |
| 2015-05-29 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 1,578 | 126.15 | 199,064 |
| 2015-05-26 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 1,625 | 126.55 | 205,647 |
| 2015-05-21 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,500 | 126.11 | 189,157 |
| 2015-05-18 | Davis George Eric (SVP, General Counsel) | Sale | 2,558 | 125.26 | 320,415 |
| 2015-05-18 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 36,137 | 127.39 | 4,687,045 |
| 2015-05-18 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 1,864 | 124.78 | 232,584 |
| 2015-05-13 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 1,434 | 121.36 | 174,037 |
| 2015-05-11 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 2,869 | 121.64 | 348,988 |
| 2015-05-06 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 34,019 | 119.17 | 4,053,942 |
| 2015-05-06 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Option Ex | 33,631 | 30.43 | 1,023,290 |
| 2015-05-01 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 26,723 | 114.98 | 3,072,503 |
| 2015-05-01 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 23,218 | 6.46 | 149,988 |
| 2015-05-01 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 414 | 114.59 | 47,441 |
| 2015-04-01 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 26,052 | 120.53 | 3,140,125 |
| 2015-04-01 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 22,546 | 6.46 | 145,647 |
| 2015-03-20 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,000 | 126.40 | 126,396 |
| 2015-03-17 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,000 | 124.87 | 124,866 |
| 2015-03-16 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,000 | 123.48 | 123,477 |
| 2015-03-16 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 41,315 | 123.57 | 5,105,170 |
| 2015-03-16 | Fuchs Henry J (EVP, Chief Medical Officer) | Option Ex | 40,000 | 21.51 | 860,400 |
| 2015-03-13 | Davis George Eric (SVP, General Counsel) | Sale | 15,000 | 120.87 | 1,813,005 |
| 2015-03-13 | Davis George Eric (SVP, General Counsel) | Option Ex | 15,000 | 31.98 | 479,625 |
| 2015-03-10 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,021 | 114.89 | 232,200 |
| 2015-03-09 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 19,000 | 112.13 | 2,130,508 |
| 2015-03-09 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 15,000 | 12.99 | 194,850 |
| 2015-03-05 | Baffi Robert (EVP, Technical Operations) | Sale | 14,051 | 116.37 | 1,635,086 |
| 2015-03-05 | Baffi Robert (EVP, Technical Operations) | Option Ex | 14,051 | 16.12 | 226,572 |
| 2015-03-05 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 113.70 | 1,137,020 |
| 2015-03-05 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 12.99 | 129,900 |
| 2015-03-04 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 916 | 107.71 | 98,660 |
| 2015-03-04 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 500 | 9.86 | 4,930 |
| 2015-03-03 | Mueller Brian (VP, Corporate Controller) | Sale | 7,000 | 109.46 | 766,213 |
| 2015-03-03 | Mueller Brian (VP, Corporate Controller) | Option Ex | 7,000 | 28.23 | 197,610 |
| 2015-03-03 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 107.42 | 537,095 |
| 2015-03-03 | Lapalme Pierre | Sale | 20,000 | 106.57 | 2,131,400 |
| 2015-03-03 | Lapalme Pierre | Option Ex | 20,000 | 14.24 | 284,800 |
| 2015-03-02 | Davis George Eric (SVP, General Counsel) | Sale | 23,000 | 108.31 | 2,491,038 |
| 2015-03-02 | Davis George Eric (SVP, General Counsel) | Option Ex | 23,000 | 26.49 | 609,270 |
| 2015-03-02 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 15,500 | 107.00 | 1,658,500 |
| 2015-03-02 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Option Ex | 15,500 | 39.06 | 605,430 |
| 2015-03-02 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 8,000 | 108.20 | 865,616 |
| 2015-03-02 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 3,000 | 12.99 | 38,970 |
| 2015-01-09 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,000 | 94.14 | 188,286 |
| 2014-12-24 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 88.73 | 443,655 |
| 2014-12-24 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 3,000 | 12.99 | 38,970 |
| 2014-12-10 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,000 | 95.00 | 190,000 |
| 2014-12-10 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 2,000 | 12.99 | 25,980 |
| 2014-12-04 | Lewis Alan | Sale | 7,500 | 89.90 | 674,227 |
| 2014-12-04 | Lewis Alan | Option Ex | 7,500 | 21.51 | 161,325 |
| 2014-12-03 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 12,000 | 91.01 | 1,092,156 |
| 2014-12-03 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Option Ex | 12,000 | 38.59 | 463,080 |
| 2014-12-02 | Mueller Brian (VP, Corporate Controller) | Sale | 5,000 | 91.82 | 459,099 |
| 2014-12-02 | Mueller Brian (VP, Corporate Controller) | Option Ex | 5,000 | 28.23 | 141,150 |
| 2014-12-01 | Mueller Brian (VP, Corporate Controller) | Sale | 6,950 | 90.25 | 627,237 |
| 2014-12-01 | Mueller Brian (VP, Corporate Controller) | Option Ex | 6,950 | 17.95 | 124,752 |
| 2014-11-26 | Mueller Brian (VP, Corporate Controller) | Sale | 3,400 | 88.97 | 302,508 |
| 2014-11-25 | Davis George Eric (SVP, General Counsel) | Sale | 20,000 | 89.75 | 1,795,000 |
| 2014-11-25 | Davis George Eric (SVP, General Counsel) | Option Ex | 20,000 | 26.49 | 529,800 |
| 2014-11-25 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,000 | 90.00 | 180,000 |
| 2014-11-25 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 2,000 | 12.99 | 25,980 |
| 2014-11-12 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,000 | 81.51 | 81,513 |
| 2014-11-10 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 87.00 | 348,000 |
| 2014-11-10 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 12.99 | 51,960 |
| 2014-11-10 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 20,000 | 86.55 | 1,730,980 |
| 2014-11-10 | Fuchs Henry J (EVP, Chief Medical Officer) | Option Ex | 20,000 | 21.51 | 430,200 |
| 2014-11-03 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 47 | 83.54 | 3,926 |
| 2014-11-03 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 3,000 | 85.33 | 256,002 |
| 2014-10-30 | Davis George Eric (SVP, General Counsel) | Sale | 15,000 | 83.19 | 1,247,925 |
| 2014-10-30 | Davis George Eric (SVP, General Counsel) | Option Ex | 15,000 | 26.49 | 397,350 |
| 2014-10-30 | Baffi Robert (EVP, Technical Operations) | Sale | 29,963 | 81.70 | 2,447,947 |
| 2014-10-30 | Baffi Robert (EVP, Technical Operations) | Option Ex | 29,963 | 38.59 | 1,156,272 |
| 2014-10-29 | Baffi Robert (EVP, Technical Operations) | Sale | 45,462 | 81.10 | 3,686,968 |
| 2014-10-29 | Baffi Robert (EVP, Technical Operations) | Option Ex | 45,462 | 24.49 | 1,113,227 |
| 2014-10-24 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,000 | 80.00 | 160,000 |
| 2014-10-24 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 2,000 | 12.99 | 25,980 |
| 2014-10-21 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,000 | 75.00 | 150,000 |
| 2014-10-21 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 2,000 | 12.99 | 25,980 |
| 2014-09-19 | Davis George Eric (SVP, General Counsel) | Sale | 17,536 | 69.75 | 1,223,136 |
| 2014-09-19 | Davis George Eric (SVP, General Counsel) | Option Ex | 17,536 | 21.51 | 377,199 |
| 2014-09-03 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 18 | 69.77 | 1,255 |
| 2014-09-02 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 16,000 | 69.83 | 1,117,312 |
| 2014-09-02 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Option Ex | 16,000 | 39.06 | 624,960 |
| 2014-08-20 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 70.00 | 350,000 |
| 2014-08-20 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 12.99 | 64,950 |
| 2014-08-05 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 10,000 | 65.00 | 650,000 |
| 2014-08-05 | Fuchs Henry J (EVP, Chief Medical Officer) | Option Ex | 10,000 | 21.51 | 215,100 |
| 2014-08-01 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 2,229 | 61.76 | 137,651 |
| 2014-07-02 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 2,229 | 64.00 | 142,656 |
| 2014-06-04 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,000 | 62.52 | 62,521 |
| 2014-06-03 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,000 | 59.88 | 59,876 |
| 2014-06-02 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 377 | 57.84 | 21,803 |
| 2014-05-22 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,000 | 56.88 | 56,876 |
| 2014-05-21 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,545 | 56.19 | 86,816 |
| 2014-05-16 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 1,004 | 56.91 | 57,135 |
| 2014-05-16 | Lawlis V Bryan | Sale | 1,700 | 56.87 | 96,672 |
| 2014-05-16 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 1,864 | 56.86 | 105,994 |
| 2014-05-13 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 478 | 58.18 | 27,809 |
| 2014-05-13 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 1,434 | 58.23 | 83,497 |
| 2014-05-09 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 621 | 57.96 | 35,991 |
| 2014-05-09 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 3,479 | 57.91 | 201,475 |
| 2014-05-02 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 11 | 58.40 | 642 |
| 2014-05-01 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 666 | 59.55 | 39,660 |
| 2014-05-01 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 715 | 59.67 | 42,666 |
| 2014-03-28 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 2,000 | 12.99 | 25,980 |
| 2014-03-06 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 17,370 | 78.63 | 1,365,837 |
| 2014-03-06 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Option Ex | 17,370 | 24.87 | 431,991 |
| 2014-03-05 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 12 | 82.93 | 995 |
| 2014-03-03 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 8,000 | 80.32 | 642,528 |
| 2014-03-03 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Option Ex | 8,000 | 39.06 | 312,480 |
| 2014-02-20 | Davis George Eric (SVP, General Counsel) | Sale | 20,000 | 80.00 | 1,600,000 |
| 2014-02-20 | Davis George Eric (SVP, General Counsel) | Option Ex | 20,000 | 21.51 | 430,200 |
| 2014-02-20 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 8,000 | 80.00 | 640,000 |
| 2014-02-06 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 12.99 | 51,960 |
| 2014-02-03 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 10,000 | 67.70 | 676,970 |
| 2014-02-03 | Fuchs Henry J (EVP, Chief Medical Officer) | Option Ex | 10,000 | 21.51 | 215,100 |
| 2014-01-10 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 70.00 | 350,000 |
| 2014-01-10 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 12.99 | 64,950 |
| 2014-01-06 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 67.41 | 674,100 |
| 2014-01-06 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 12.99 | 129,900 |
| 2014-01-02 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 68.90 | 344,485 |
| 2014-01-02 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 12.99 | 64,950 |
| 2014-01-02 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 916 | 68.97 | 63,171 |
| 2013-12-24 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 68.71 | 687,140 |
| 2013-12-11 | Grey Michael G | Sale | 30,000 | 69.66 | 2,089,680 |
| 2013-12-11 | Grey Michael G | Option Ex | 30,000 | 21.78 | 653,310 |
| 2013-12-09 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Sale | 13,026 | 69.55 | 906,010 |
| 2013-12-09 | Ajer Jeffrey Robert (SVP, Chief Commercial Of) | Option Ex | 13,026 | 17.92 | 233,425 |
| 2013-12-09 | Lawlis V Bryan | Sale | 2,900 | 69.76 | 202,301 |
| 2013-12-09 | Lewis Alan | Sale | 22,500 | 69.91 | 1,572,975 |
| 2013-12-09 | Lewis Alan | Option Ex | 22,500 | 32.54 | 732,150 |
| 2013-12-05 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 69.70 | 348,485 |
| 2013-12-02 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 9,000 | 70.14 | 631,269 |
| 2013-12-02 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Option Ex | 9,000 | 39.06 | 351,540 |
| 2013-11-14 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 12.99 | 64,950 |
| 2013-11-05 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 62.36 | 311,780 |
Insider trading activities including stock purchases, stock sales, and option exercises
of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN,
CIK number 1048477) see
the Securities and Exchange Commission (SEC) website.